BlackRock Fund Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$407M Buy
13,038,135
+25,383
+0.2% +$822K 0.08% 264
2016
Q3
$523M Buy
13,012,752
+430,044
+3% +$16.2M 0.11% 174
2016
Q2
$418M Buy
12,582,708
+554,616
+5% +$19M 0.09% 209
2016
Q1
$354M Buy
12,028,092
+12,231
+0.1% +$337K 0.08% 243
2015
Q4
$316M Buy
12,015,861
+616,953
+5% +$16M 0.07% 276
2015
Q3
$270M Sell
11,398,908
-206,058
-2% -$4.97M 0.07% 297
2015
Q2
$275M Buy
11,604,966
+606,780
+6% +$13.7M 0.07% 321
2015
Q1
$261M Buy
10,998,186
+445,452
+4% +$9.99M 0.06% 349
2014
Q4
$224M Buy
10,552,734
+851,586
+9% +$17.1M 0.06% 391
2014
Q3
$165M Buy
9,701,148
+362,970
+4% +$5.73M 0.05% 489
2014
Q2
$134M Sell
9,338,178
-182,064
-2% -$2.47M 0.04% 659
2014
Q1
$118M Buy
9,520,242
+224,562
+2% +$2.59M 0.03% 719
2013
Q4
$102M Buy
9,295,680
+1,068,600
+13% +$12M 0.03% 828
2013
Q3
$95.5M Buy
8,227,080
+402,096
+5% +$4.7M 0.03% 788
2013
Q2
$87.6M Buy
+7,824,984
New +$92.6M 0.03% 751

Other funds holding EW

BlackRock Fund Advisors's EW Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Edwards Lifesciences (EW) stake by 0.2% in Q4 2016, buying an estimated $822K and bringing the position to 13,038,135 shares worth $407M. The position accounts for 0.08% of the portfolio, ranked #264.

BlackRock Fund Advisors first reported a position in EW in Q2 2013 and has held it in 15 quarters since. The position peaked at $523M in Q3 2016. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

  • BlackRock Fund Advisors held 13,038,135 shares of Edwards Lifesciences worth $407M as of Q4 2016.
  • BlackRock Fund Advisors bought 25,383 Edwards Lifesciences shares in Q4 2016, an estimated $822K.
  • Edwards Lifesciences made up 0.08% of BlackRock Fund Advisors's portfolio in Q4 2016, its #264 holding.
  • BlackRock Fund Advisors first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Edwards Lifesciences position peaked at $523M in Q3 2016.
  • 686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.